Related Experiment Video

Updated: Dec 12, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.6K

Invited Commentary: Prostate-specific Membrane Antigen PET Response Assessment-Has the Time Come?

Tara D Barwick1, Paolo Castellucci1

  • 1From the Department of Radiology/Nuclear Medicine, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London W6 8RF, England (T.D.B); and Department of Nuclear Medicine, Policlinico S. Orsola-Malpighi, Bologna, Italy (P.C).

Radiographics : a Review Publication of the Radiological Society of North America, Inc
|August 11, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.3K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

854

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.7K